Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)
CUSIP: 29337E102
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 58,923,077
- Total 13F shares
- 49,624,914
- Share change
- +1,247,117
- Total reported value
- $1,116,597,658
- Put/Call ratio
- 27%
- Price per share
- $22.50
- Number of holders
- 111
- Value change
- +$24,828,957
- Number of buys
- 58
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 29337E102?
CUSIP 29337E102 identifies ELVN - Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29337E102:
Top shareholders of ELVN - Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director, 10%+ Owner |
14%
|
7,959,538
|
$203,286,601 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
11%
|
6,296,179
|
$160,804,412 | — | 30 Sep 2024 | |
| Commodore Capital LP |
13F
3/4/5
|
Company · 10%+ Owner |
7%
|
4,100,000
|
$104,714,000 | — | 30 Sep 2024 | |
| VR Adviser, LLC |
13F
|
Company |
6.8%
|
4,026,331
|
$102,832,494 | — | 30 Sep 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
5.4%
|
3,202,798
|
$81,799,461 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5%
|
2,936,642
|
$75,001,838 | — | 30 Sep 2024 | |
| David P. Bonita |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
4,207,568
mixed-class rows
|
$63,552,894 | — | 02 Jun 2022 | |
| 5AM Partners VI, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,835,975
|
$57,156,028 | — | 14 Feb 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
1,920,372
|
$49,046,301 | — | 30 Sep 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
3%
|
1,752,174
|
$44,750,524 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.9%
|
1,733,977
|
$44,285,773 | — | 30 Sep 2024 | |
| New Enterprise Associates 14, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,611,050
|
$39,518,242 | — | 05 Apr 2022 | |
| Mark Chin |
3/4/5
|
Director |
—
mixed-class rows
|
2,352,572
mixed-class rows
|
$35,477,530 | — | 02 Jun 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
3/4/5
13F
|
Former 10% owner · Company |
1.8%
from 13F
|
2,122,465
|
$32,123,508 | — | 23 Feb 2023 | |
| Braden M. Leonard |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,997,774
|
$30,236,309 | — | 03 Jan 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.8%
|
1,041,724
|
$26,610,840 | — | 30 Sep 2024 | |
| Barbara Dalton |
3/4/5
|
Director |
—
mixed-class rows
|
1,566,222
mixed-class rows
|
$23,576,122 | — | 02 Jun 2022 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.4%
|
836,324
|
$21,359,715 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.4%
|
806,187
|
$20,590,016 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
800,000
|
$20,432,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
750,208
|
$19,163,957 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
745,944
|
$19,051,410 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.1%
|
671,358
|
$17,146,483 | — | 30 Sep 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.1%
|
650,000
|
$16,601,000 | — | 30 Sep 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.91%
|
535,092
|
$13,666,250 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.85%
|
499,566
|
$12,758,915 | — | 30 Sep 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.84%
|
495,000
|
$12,642,300 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.73%
|
428,571
|
$10,945,703 | — | 30 Sep 2024 | |
| Carl Goldfischer |
3/4/5
|
Director |
—
mixed-class rows
|
711,880
mixed-class rows
|
$10,645,656 | — | 02 Jun 2022 | |
| Blackstone Inc. |
13F
|
Company |
0.63%
|
373,323
|
$9,534,669 | — | 30 Sep 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.54%
|
321,055
|
$8,199,000 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.52%
|
304,396
|
$7,774,274 | — | 30 Sep 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.5%
|
296,368
|
$7,569,239 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
255,277
|
$6,519,775 | — | 30 Sep 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.41%
|
239,705
|
$6,122,066 | — | 30 Sep 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.4%
|
234,856
|
$5,998,222 | — | 30 Sep 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.35%
|
207,896
|
$5,309,664 | — | 30 Sep 2024 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.29%
|
173,745
|
$4,437,447 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.23%
|
138,006
|
$3,524,674 | — | 30 Sep 2024 | |
| David M. Mott |
3/4/5
|
Director |
—
mixed-class rows
|
237,724
mixed-class rows
|
$3,469,305 | — | 02 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.23%
|
135,407
|
$3,458,293 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
132,833
|
$3,392,555 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
121,785
|
$3,110,389 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.19%
|
114,833
|
$2,932,835 | — | 30 Sep 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.19%
|
112,459
|
$2,872,203 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
103,709
|
$2,648,727 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.17%
|
99,416
|
$2,539,085 | — | 30 Sep 2024 | |
| Patient Square Capital LP |
13F
|
Company |
0.15%
|
90,572
|
$2,313,209 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
90,403
|
$2,308,893 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.12%
|
70,170
|
$1,792,142 | — | 30 Sep 2024 |
Institutional Holders of Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN) as of Q4 2024
As of 31 Dec 2024,
Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,624,914 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, COMMODORE CAPITAL LP, VR Adviser, LLC, Fairmount Funds Management LLC, BlackRock, Inc., Polar Capital Holdings Plc, VANGUARD GROUP INC, CITADEL ADVISORS LLC, and 5AM Venture Management, LLC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
100
Q4 2024 holders
111
Holder diff
11
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.